Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Bob Rudd who wrote (14158)	3/23/2002 2:20:25 PM
From: Paul Senior	Read Replies (1) \| Respond to of 78593

Bob R., looks to me like you succinctly stated the concerns about pharmaceuticals. The recent drugs coming off patent and no line-of-sight to replacement blockbusters auger poorly for some of these drug giants. I have a very over-sized position in BMY. For now, I've decided to override my inclination to reduce my position; instead, I started yesterday to add more. The near term situation for BMY stock looks bleak. (The latest problem according to today's Barron's is that BMY is about to be sued for patent infringement on one of their important drugs.) Two years from now though, the situation near term for BMY then may not be looking so grim, their drug pipeline might not be considered so empty, and maybe the stock's health might be improving. Paul Senior